AORT ARTIVION, INC.
NYSE · SEC CIK 784199 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $20.73M 46 sales by 8 insiders
- Filings on record
- 315 since 2021-08-24, latest 2026-09-11 17:28
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Mackin James P | Pres, CEO | — | $9.72M |
| Stanton Marshall S. | SVP, Clinical, MD Affair | — | $3.43M |
| Holloway Jean F | SVP, GC | — | $2.54M |
| Davis John E | Chief Commercial Off | — | $1.75M |
| GREEN ANDREW M | SVP, Regulatory, Quality | — | $1.43M |
| Horton Amy | VP, CAO | — | $870.1K |
| Berry Lance A | EVP, COO, CFO, Treas | — | $803.2K |
| Hoff Elizabeth A | Dir | — | $189.4K |
| SEMEDO ANTHONY B. | Dir | — | — |
| Borgstrom Marna P | Dir | — | — |
Transactions 430
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-03 | 2023-03-01 | AORT | Holloway Jean F | SVP, GC | A - Grant | $0.00 | +3,663 | 134.4K | +3% | $0 | |
| 2023-03-03 | 2023-03-01 | AORT | GREEN ANDREW M | VP Regulatory | A - Grant | $0.00 | +2,290 | 26.4K | +10% | $0 | |
| 2023-03-03 | 2023-03-02 | AORT | GREEN ANDREW M | VP Regulatory | S - Sale | $13.41 | -825 | 25.6K | -3% | -$11.1K | |
| M | 2023-03-01 | 2023-02-23 | AORT | Getz Matthew A | VP, Human Resources | A - Grant | $0.00 | +6,596 | 35.9K | +23% | $0 |
| M | 2023-03-01 | 2023-02-27 | AORT | Getz Matthew A | VP, Human Resources | S - Sale | $12.94 | -1,600 | 35.1K | -4% | -$20.7K |
| M | 2023-03-01 | 2023-02-27 | AORT | Maier Dennis B | SVP, Ops | S - Sale | $12.94 | -2,330 | 43.1K | -5% | -$30.2K |
| M | 2023-03-01 | 2023-02-23 | AORT | Maier Dennis B | SVP, Ops | A - Grant | $0.00 | +10.1K | 49.4K | +26% | $0 |
| M | 2023-03-01 | 2023-02-23 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +11.2K | 50.5K | +29% | $0 |
| M | 2023-03-01 | 2023-02-27 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $12.94 | -2,337 | 49.3K | -5% | -$30.2K |
| M | 2023-03-01 | 2023-02-27 | AORT | Holloway Jean F | SVP, GC | S - Sale | $12.94 | -1,960 | 130.8K | -1% | -$25.4K |
| M | 2023-03-01 | 2023-02-23 | AORT | Holloway Jean F | SVP, GC | A - Grant | $0.00 | +11.5K | 131.8K | +10% | $0 |
| M | 2023-03-01 | 2023-02-27+ | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $13.03 | -1,284 | 28.1K | -4% | -$16.7K |
| M | 2023-03-01 | 2023-02-23+ | AORT | Maney Rochelle L. | VP, Quality | A - Grant | $1.38 | +5,806 | 29.3K | +25% | +$8,036 |
| M | 2023-03-01 | 2023-02-27 | AORT | Mackin James P | Pres, CEO | S - Sale | $12.94 | -22.6K | 540.1K | -4% | -$292.8K |
| M | 2023-03-01 | 2023-02-23 | AORT | Mackin James P | Pres, CEO | A - Grant | $0.00 | +70.4K | 550.0K | +15% | $0 |
| M | 2023-03-01 | 2023-02-23 | AORT | LEE DAVID ASHLEY | COO, CFO, Executive VP | A - Grant | $0.00 | +14.8K | 345.6K | +4% | $0 |
| M | 2023-03-01 | 2023-02-27 | AORT | LEE DAVID ASHLEY | COO, CFO, Executive VP | S - Sale | $12.94 | -3,094 | 344.0K | -0.9% | -$40.0K |
| M | 2023-03-01 | 2023-02-27 | AORT | GREEN ANDREW M | VP Regulatory | S - Sale | $12.94 | -1,747 | 20.3K | -8% | -$22.6K |
| M | 2023-03-01 | 2023-02-23 | AORT | GREEN ANDREW M | VP Regulatory | A - Grant | $0.00 | +7,018 | 25.0K | +39% | $0 |
| M | 2023-03-01 | 2023-02-27 | AORT | Davis John E | Senior VP, Gbl Sales | S - Sale | $12.94 | -2,393 | 119.8K | -2% | -$31.0K |
| M | 2023-03-01 | 2023-02-23 | AORT | Davis John E | Senior VP, Gbl Sales | A - Grant | $0.00 | +11.4K | 121.0K | +10% | $0 |
| M | 2023-03-01 | 2023-02-23 | AORT | Horton Amy | VP, CAO | A - Grant | $0.00 | +6,596 | 106.8K | +7% | $0 |
| M | 2023-03-01 | 2023-02-27 | AORT | Horton Amy | VP, CAO | S - Sale | $12.94 | -1,419 | 106.1K | -1% | -$18.4K |
| M | 2023-02-21 | 2023-02-17+ | AORT | Davis John E | Senior VP, Gbl Sales | F - Tax | $13.96 | -2,833 | 117.2K | -2% | -$39.5K |
| DM | 2023-02-21 | 2023-02-17 | AORT | Horton Amy | VP, CAO | M - OptEx | $10.24 | +20.7K | 117.7K | +21% | +$212.1K |
| DM | 2023-02-21 | 2023-02-17 | AORT | Horton Amy | VP, CAO | S - Sale+OE | $14.09 | -18.0K | 102.7K | -15% | -$253.6K |
| DM | 2023-02-21 | 2023-02-17+ | AORT | Horton Amy | VP, CAO | F - Tax | $13.96 | -1,728 | 102.3K | -2% | -$24.1K |
| 2023-02-21 | 2023-02-17 | AORT | Maney Rochelle L. | VP, Quality | F - Tax | $13.96 | -403 | 23.5K | -2% | -$5,626 | |
| M | 2023-02-21 | 2023-02-17+ | AORT | Mackin James P | Pres, CEO | F - Tax | $13.96 | -13.4K | 492.3K | -3% | -$187.5K |
| M | 2023-02-21 | 2023-02-17+ | AORT | Holloway Jean F | SVP, GC | F - Tax | $13.96 | -3,685 | 121.5K | -3% | -$51.4K |
| M | 2023-02-21 | 2023-02-17+ | AORT | Maier Dennis B | SVP, Ops | F - Tax | $13.96 | -1,787 | 40.7K | -4% | -$24.9K |
| M | 2023-02-21 | 2023-02-17+ | AORT | Getz Matthew A | VP, Human Resources | F - Tax | $13.96 | -1,770 | 31.5K | -5% | -$24.7K |
| M | 2023-02-21 | 2023-02-17+ | AORT | LEE DAVID ASHLEY | COO, CFO, Executive VP | F - Tax | $13.96 | -3,265 | 332.8K | -1.0% | -$45.6K |
| D | 2023-02-16 | 2023-02-14 | AORT | Mackin James P | Pres, CEO | M - OptEx | $10.24 | +65.5K | 562.2K | +13% | +$671.2K |
| D | 2023-02-16 | 2023-02-14 | AORT | Mackin James P | Pres, CEO | S - Sale+OE | $13.22 | -56.5K | 505.7K | -10% | -$746.9K |
| D | 2023-02-16 | 2023-02-14 | AORT | LEE DAVID ASHLEY | COO, CFO, Executive VP | S - Sale+OE | $13.22 | -31.9K | 335.6K | -9% | -$421.7K |
| D | 2023-02-16 | 2023-02-14 | AORT | LEE DAVID ASHLEY | COO, CFO, Executive VP | M - OptEx | $10.24 | +36.8K | 367.5K | +11% | +$377.1K |
| D | 2023-02-15 | 2023-02-13 | AORT | Davis John E | Senior VP, Gbl Sales | M - OptEx | $10.24 | +8,745 | 120.0K | +8% | +$89.5K |
| 2022-12-16 | 2022-12-14 | AORT | Horton Amy | VP, CAO | G - Gift | $13.21 | -2,000 | 100.0K | -2% | -$26.4K | |
| 2022-12-16 | 2022-12-14 | AORT | Horton Amy | VP, CAO | S - Sale | $13.57 | -3,226 | 102.0K | -3% | -$43.8K | |
| 2022-11-10 | 2022-11-08 | AORT | Hoff Elizabeth A | Dir | A - Grant | $0.00 | +9,066 | 9,066 | New | $0 | |
| D | 2022-11-10 | 2022-11-08 | AORT | GREEN ANDREW M | VP Regulatory | A - Grant | $0.00 | +12.5K | 18.8K | +198% | $0 |
| D | 2022-11-10 | 2022-11-08 | AORT | Davis John E | Senior VP, Gbl Sales | A - Grant | $0.00 | +22.3K | 110.0K | +25% | $0 |
| D | 2022-11-10 | 2022-11-08 | AORT | Holloway Jean F | SVP, GC | A - Grant | $0.00 | +22.4K | 123.6K | +22% | $0 |
| D | 2022-11-10 | 2022-11-08 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +19.4K | 39.2K | +98% | $0 |
| D | 2022-11-10 | 2022-11-08 | AORT | LEE DAVID ASHLEY | COO, CFO, Executive VP | A - Grant | $0.00 | +36.7K | 330.6K | +12% | $0 |
| D | 2022-11-10 | 2022-11-08 | AORT | Mackin James P | Pres, CEO | A - Grant | $0.00 | +117.0K | 496.6K | +31% | $0 |
| D | 2022-11-10 | 2022-11-08 | AORT | Barthold Franz Peter | VP, Research, Development | A - Grant | $0.00 | +12.5K | 32.5K | +63% | $0 |
| D | 2022-11-10 | 2022-11-08 | AORT | Horton Amy | VP, CAO | A - Grant | $0.00 | +11.8K | 105.2K | +13% | $0 |
| D | 2022-11-10 | 2022-11-08 | AORT | Maier Dennis B | SVP, Ops | A - Grant | $0.00 | +19.4K | 42.3K | +85% | $0 |
| D | 2022-11-10 | 2022-11-08 | AORT | Maney Rochelle L. | VP, Quality | A - Grant | $0.00 | +11.8K | 23.9K | +98% | $0 |
| D | 2022-11-10 | 2022-11-08 | AORT | Getz Matthew A | VP, Human Resources | A - Grant | $0.00 | +13.2K | 31.9K | +70% | $0 |
| 2022-11-07 | 2022-11-04 | AORT | Maney Rochelle L. | VP, Quality | F - Tax | $11.18 | -214 | 12.1K | -2% | -$2,393 | |
| 2022-08-18 | 2022-08-16 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $22.96 | -7,161 | 12.3K | -37% | -$164.4K | |
| M | 2022-08-10 | 2022-08-09 | AORT | Maier Dennis B | SVP, Ops | S - Sale | $21.61 | -5,762 | 23.8K | -19% | -$124.5K |
| 2022-06-03 | 2022-06-01 | AORT | BEVEVINO DANIEL J | Dir | A - Grant | $19.04 | +7,878 | 127.7K | +7% | +$150.0K | |
| 2022-06-03 | 2022-06-01 | AORT | Bullock James | Dir | A - Grant | $19.04 | +7,878 | 46.3K | +20% | +$150.0K | |
| 2022-06-03 | 2022-06-01 | AORT | Salveson Jon W | Dir | A - Grant | $19.04 | +7,878 | 107.5K | +8% | +$150.0K | |
| 2022-06-03 | 2022-06-01 | AORT | ACKERMAN THOMAS F | Dir | A - Grant | $19.04 | +7,878 | 127.6K | +7% | +$150.0K | |
| 2022-06-03 | 2022-06-01 | AORT | SEMEDO ANTHONY B. | Dir | A - Grant | $19.04 | +7,878 | 27.9K | +39% | +$150.0K | |
| 2022-06-03 | 2022-06-01 | AORT | Burbank Jeffrey H | Dir | A - Grant | $19.04 | +7,878 | 31.5K | +33% | +$150.0K | |
| 2022-06-03 | 2022-06-01 | AORT | Borgstrom Marna P | Dir | A - Grant | $19.04 | +7,878 | 26.8K | +42% | +$150.0K | |
| 2022-03-09 | 2022-03-08 | AORT | Barthold Franz Peter | VP, Research, Development | F - Tax | $20.32 | -76 | 20.0K | -0.4% | -$1,544 | |
| 2022-03-09 | 2022-03-08 | AORT | Maney Rochelle L. | VP, Quality | F - Tax | $20.32 | -81 | 19.5K | -0.4% | -$1,646 | |
| M | 2022-03-07 | 2022-03-05 | AORT | Horton Amy | VP, CAO | F - Tax | $21.69 | -1,132 | 93.3K | -1% | -$24.6K |
| M | 2022-03-07 | 2022-03-05 | AORT | Mackin James P | Pres, CEO | F - Tax | $21.69 | -13.0K | 379.7K | -3% | -$282.6K |
| M | 2022-03-07 | 2022-03-05 | AORT | Davis John E | Senior VP, Gbl Sales | F - Tax | $21.69 | -1,799 | 87.7K | -2% | -$39.0K |
| M | 2022-03-07 | 2022-03-05 | AORT | Barthold Franz Peter | VP, Research, Development | F - Tax | $21.69 | -602 | 20.2K | -3% | -$13.1K |
| M | 2022-03-07 | 2022-03-05 | AORT | Maier Dennis B | VP, Ops | F - Tax | $21.69 | -1,090 | 28.6K | -4% | -$23.6K |
| M | 2022-03-07 | 2022-03-05 | AORT | Holloway Jean F | SVP, GC | F - Tax | $21.69 | -1,799 | 101.2K | -2% | -$39.0K |
| M | 2022-03-07 | 2022-03-05 | AORT | LEE DAVID ASHLEY | COO, CFO, Executive VP | F - Tax | $21.69 | -2,146 | 293.9K | -0.7% | -$46.5K |
| 2022-03-01 | 2022-02-27 | AORT | Maney Rochelle L. | VP, Quality | F - Tax | $19.35 | -398 | 19.6K | -2% | -$7,701 | |
| D | 2022-02-24 | 2022-02-23 | AORT | Horton Amy | VP, CAO | A - Grant | $0.00 | +4,790 | 94.5K | +5% | $0 |
| D | 2022-02-24 | 2022-02-23 | AORT | LEE DAVID ASHLEY | COO, CFO, Executive VP | A - Grant | $0.00 | +11.4K | 296.1K | +4% | $0 |
| D | 2022-02-24 | 2022-02-23 | AORT | GREEN ANDREW M | VP Regulatory | A - Grant | $0.00 | +5,269 | 6,320 | +501% | $0 |
| D | 2022-02-24 | 2022-02-23 | AORT | Maney Rochelle L. | VP, Quality | A - Grant | $0.00 | +4,790 | 20.0K | +32% | $0 |
| D | 2022-02-24 | 2022-02-23 | AORT | Getz Matthew A | VP, Human Resources | A - Grant | $0.00 | +4,790 | 18.7K | +34% | $0 |
| D | 2022-02-24 | 2022-02-23 | AORT | Mackin James P | Pres, CEO | A - Grant | $0.00 | +47.6K | 392.7K | +14% | $0 |
| D | 2022-02-24 | 2022-02-23 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +8,406 | 19.7K | +74% | $0 |
| D | 2022-02-24 | 2022-02-23 | AORT | Barthold Franz Peter | VP, Research, Development | A - Grant | $0.00 | +4,790 | 20.7K | +30% | $0 |
| D | 2022-02-24 | 2022-02-23 | AORT | Davis John E | Senior VP, Gbl Sales | A - Grant | $0.00 | +8,623 | 89.5K | +11% | $0 |
| D | 2022-02-24 | 2022-02-23 | AORT | Maier Dennis B | VP, Ops | A - Grant | $0.00 | +7,140 | 29.7K | +32% | $0 |
| D | 2022-02-24 | 2022-02-23 | AORT | Holloway Jean F | SVP, GC | A - Grant | $0.00 | +8,767 | 103.0K | +9% | $0 |
| M | 2022-02-22 | 2022-02-17 | AORT | Davis John E | Senior VP, Gbl Sales | A - Grant | $0.00 | +9,797 | 80.2K | +14% | $0 |
| M | 2022-02-22 | 2022-02-17 | AORT | Davis John E | Senior VP, Gbl Sales | F - Tax | $17.50 | -2,035 | 81.3K | -2% | -$35.6K |
| M | 2022-02-22 | 2022-02-17 | AORT | Maier Dennis B | VP, Ops | F - Tax | $17.50 | -1,463 | 21.5K | -6% | -$25.6K |
| M | 2022-02-22 | 2022-02-17 | AORT | Maier Dennis B | VP, Ops | A - Grant | $0.00 | +6,275 | 23.5K | +36% | $0 |
| M | 2022-02-22 | 2022-02-17 | AORT | Horton Amy | VP, CAO | F - Tax | $17.50 | -1,418 | 88.7K | -2% | -$24.8K |
| M | 2022-02-22 | 2022-02-17 | AORT | Horton Amy | VP, CAO | A - Grant | $0.00 | +6,079 | 90.6K | +7% | $0 |
| 2022-02-22 | 2022-02-19 | AORT | Horton Amy | VP, CAO | F - Tax | $17.75 | -256 | 89.7K | -0.3% | -$4,544 | |
| 2022-02-22 | 2022-02-17 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | F - Tax | $17.50 | -772 | 11.3K | -6% | -$13.5K | |
| 2022-02-22 | 2022-02-17 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +2,603 | 12.1K | +27% | $0 | |
| M | 2022-02-22 | 2022-02-17 | AORT | Barthold Franz Peter | VP, Research, Development | A - Grant | $0.00 | +5,883 | 16.0K | +58% | $0 |
| M | 2022-02-22 | 2022-02-17 | AORT | Barthold Franz Peter | VP, Research, Development | F - Tax | $17.50 | -1,757 | 15.2K | -10% | -$30.7K |
| 2022-02-22 | 2022-02-19 | AORT | LEE DAVID ASHLEY | COO, CFO, Executive VP | F - Tax | $17.75 | -526 | 284.6K | -0.2% | -$9,336 | |
| 2022-02-22 | 2022-02-19 | AORT | Davis John E | Senior VP, Gbl Sales | F - Tax | $17.75 | -402 | 80.9K | -0.5% | -$7,136 | |
| 2022-02-22 | 2022-02-19 | AORT | Holloway Jean F | SVP, GC | F - Tax | $17.75 | -421 | 94.2K | -0.4% | -$7,473 | |
| 2022-02-22 | 2022-02-17 | AORT | GREEN ANDREW M | VP Regulatory | F - Tax | $17.50 | -576 | 1,051 | -35% | -$10.1K | |
| 2022-02-22 | 2022-02-17 | AORT | GREEN ANDREW M | VP Regulatory | A - Grant | $0.00 | +1,627 | 1,627 | New | $0 | |
| 2022-02-22 | 2022-02-19 | AORT | Getz Matthew A | VP, Human Resources | F - Tax | $17.75 | -244 | 13.9K | -2% | -$4,331 |
Purchase Sale Sale after option exercise All abbreviations